What are the latest advances in Familial Adenomatous Polyposis?

Familial Adenomatous Polyposis (FAP) research is currently focused on chemoprevention agents to delay surgery and gene-editing technologies to address the underlying APC gene mutations. While surgical intervention remains the standard of care, ongoing clinical trials are investigating non-surgical pharmacological strategies to manage polyp burden and reduce colorectal cancer risk in patients with Familial Adenomatous Polyposis.

What are the most promising research directions for Familial Adenomatous Polyposis?

The primary research focus for Familial Adenomatous Polyposis involves identifying drugs that can inhibit polyp growth. Recent studies have explored the use of non-steroidal anti-inflammatory drugs (NSAIDs) like sulindac and celecoxib, as well as newer agents like eicosapentaenoic acid (EPA). Researchers are also investigating the role of the gut microbiome in the progression of Familial Adenomatous Polyposis, hoping to uncover markers that predict which patients are at higher risk for rapid polyp development.

Are there new treatments or clinical trials for Familial Adenomatous Polyposis?

Clinical trials are actively exploring ways to manage Familial Adenomatous Polyposis without relying solely on proctocolectomy. Current research includes:

• Chemoprevention trials: Testing the efficacy of novel inhibitors to suppress adenoma formation in the duodenum and rectum.


• Precision medicine: Utilizing genetic profiling to tailor surveillance schedules based on specific APC gene mutations.


• Immunotherapy: Early-stage research investigating whether the immune system can be modulated to recognize and destroy precancerous polyps.

How can patients contribute to Familial Adenomatous Polyposis research?

The 147 members of the DiseaseMaps community for Familial Adenomatous Polyposis emphasize the importance of data sharing. Patients can contribute by participating in longitudinal registries and searching for active studies on ClinicalTrials.gov using the search term "Familial Adenomatous Polyposis." Always discuss potential trial participation with your gastroenterologist or genetic counselor to ensure it aligns with your specific clinical history.

Next steps

• Consult a specialist in hereditary colorectal cancer syndromes to review your surveillance plan.


• Register on ClinicalTrials.gov to receive alerts for new Familial Adenomatous Polyposis studies.


• Connect with the DiseaseMaps community to share experiences and learn about patient-led advocacy efforts.


• Maintain consistent screening intervals as recommended by your clinical team.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases (GARD) Information Center: Familial Adenomatous Polyposis


• Orphanet: Familial Adenomatous Polyposis (ORPHA:733)


• OMIM (Online Mendelian Inheritance in Man): Adenomatous Polyposis of the Colon


• PubMed: Recent clinical reviews on APC-associated polyposis conditions